Base
N3385332024-03-20New YorkClassification

The tariff classification of Trospium Chloride (CAS No. 10405-02-4) in bulk form, from Italy

U.S. Customs and Border Protection · CROSS Database · 1 HTS code referenced

Cross-Source Intelligence

Data compiled from CBP CROSS Rulings, Census Bureau Trade Data · As of 2026-05-06 · Updates monthly

Summary

The tariff classification of Trospium Chloride (CAS No. 10405-02-4) in bulk form, from Italy

Ruling Text

N338533 March 20, 2024 CLA-2-29:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 2939.79.0000 Patricia Luhrs Procos USA, Inc. 1350 6th Avenue, 30th Floor New York, NY 10019 RE:  The tariff classification of Trospium Chloride (CAS No. 10405-02-4) in bulk form, from Italy Dear Ms. Luhrs: In your letter dated February 29, 2024, you requested a tariff classification ruling. Trospium Chloride is an atropine derivative. Atropine is a synthetically-derived form of the endogenous alkaloid isolated from the plant Atropa belladonna. Trospium Chloride is an antispasmodic, antimuscarinic agent indicated for the treatment of overactive bladder with symptoms of urinary incontinence, urgency, and urinary frequency. The applicable subheading for the Trospium Chloride in bulk form will be 2939.79.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives: Other, of vegetal origin: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided at https://hts.usitc.gov/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. The holding set forth above applies only to the specific factual situation and merchandise description as identified in the ruling request. This position is clearly set forth in Title 19, Code of Federal Regulations (CFR), Section 177.9(b)(1). This section states that a ruling letter is issued on the assumption that all of the information furnished in the ruling letter, whether directly, by reference, or by implication, is accurate and complete in every material respect. In the event that the facts are modified in any way, or if the goods do not conform to these facts at time of importation, you should bring this to the attention of U.S. Customs and Border Protection (CBP) and submit a request for a new ruling in accordance with 19 CFR 177.2. Additionally, we note that the material facts described in the foregoing ruling may be subject to periodic verification by CBP. This ruling is being issued under the provisions of Part 177 of the Customs and Border Protection Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, please contact National Import Specialist Judy Lee at judy.h.lee@cbp.dhs.gov. Sincerely, Steven A. Mack Director National Commodity Specialist Division